CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
OPERATING ACTIVITIES
Net (loss) income	$ (157,820)	$ (393,129)
Adjustments for non-cash items:
Depreciation	73,297	79,281
Amortization	16,315	20,361
Stock-based compensation expense	14,705	14,252
Restructuring and asset impairment charges (Notes 8 and 18)	111,922	543,942
Deferred income tax provision	(85,426)	(51,766)
Loss on divestiture (Note 5)	130,750	0
Other	239	2,632
Changes in certain assets and liabilities:
Accounts receivable	44,125	34,287
Inventories	47,778	6,582
Accounts Payable and Accrued Liabilities	(16,244)	(21,690)
Accrued income taxes	(12,989)	(9,874)
Accrued pension and postretirement benefits	(22,901)	(12,369)
Other	1,663	7,067
Net cash flow provided by operating activities	145,414	219,576
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(83,285)	(77,620)
Disposals of property, plant and equipment	5,102	1,300
Proceeds from divestiture (Note 5)	61,100	0
Other	835	43
Net cash flow used for investing activities	(16,248)	(76,277)
FINANCING ACTIVITIES
Net (decrease) increase in notes payable	(4,088)	17,090
Net increase in short-term revolving and other lines of credit	0	3,600
Term debt borrowings	50,070	62,950
Term debt repayments	(94,337)	(212,638)
Purchase of capital stock	(231)	(244)
Dividend reinvestment and the effect of employee benefit and stock plans	1,713	10,977
Cash dividends paid to shareholders	(47,780)	(42,699)
Other	(55)	(3,824)
Net cash flow used for financing activities	(94,708)	(164,788)
Effect of exchange rate changes on cash and cash equivalents	(3,388)	(10,265)
CASH AND CASH EQUIVALENTS
Net increase (decrease) in cash and cash equivalents	31,070	(31,754)
Cash and cash equivalents, beginning of period	105,494	177,929
Cash and cash equivalents, end of period	$ 136,564	$ 146,175